Fintel reports that on December 1, 2025, Mizuho maintained coverage of Harmony Biosciences Holdings (NasdaqGM:HRMY) with a ...
Fintel reports that on November 24, 2025, HC Wainwright & Co. reiterated coverage of Harmony Biosciences Holdings (NasdaqGM:HRMY) with a Buy recommendation. Analyst Price Forecast Suggests 35.40% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback